López-Vega, J.M.; Álvarez, I.; Antón, A.; Illarramendi, J.J.; Llombart, A.; Boni, V.; García-Velloso, M.J.; Martí-Climent, J.M.; Pina, L.; García-Foncillas, J.
Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer. Cancers 2021, 13, 3511.
https://doi.org/10.3390/cancers13143511
AMA Style
López-Vega JM, Álvarez I, Antón A, Illarramendi JJ, Llombart A, Boni V, García-Velloso MJ, Martí-Climent JM, Pina L, García-Foncillas J.
Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer. Cancers. 2021; 13(14):3511.
https://doi.org/10.3390/cancers13143511
Chicago/Turabian Style
López-Vega, José Manuel, Isabel Álvarez, Antonio Antón, José Juan Illarramendi, Antonio Llombart, Valentina Boni, María José García-Velloso, Josep María Martí-Climent, Luis Pina, and Jesús García-Foncillas.
2021. "Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer" Cancers 13, no. 14: 3511.
https://doi.org/10.3390/cancers13143511
APA Style
López-Vega, J. M., Álvarez, I., Antón, A., Illarramendi, J. J., Llombart, A., Boni, V., García-Velloso, M. J., Martí-Climent, J. M., Pina, L., & García-Foncillas, J.
(2021). Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer. Cancers, 13(14), 3511.
https://doi.org/10.3390/cancers13143511